All events

Launching the IP PACT: Our approach to Intellectual Property with patient and societal benefit at its core

April 26, 2021- April 26, 2021/ 11:00 am - 3:00 pm

Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.


Jean-Christophe Tellier,

CEO, UCB & Chair of the Biopharmaceutical CEO Roundtable (BCR)

Paola Barbarino

CEO, Alzheimer’s Disease International

Sune Stampe Sørensen

Director General, Danish Patent and Trademark Office

Thomas Cueni

Director General, IFPMA


Previous Event

Next Event